R
Rachel Grimley
Researcher at GlaxoSmithKline
Publications - 7
Citations - 467
Rachel Grimley is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Rhodospirillum rubrum & Sirtuin. The author has an hindex of 5, co-authored 7 publications receiving 438 citations.
Papers
More filters
Journal ArticleDOI
Discovery and Characterization of Small Molecule Inhibitors of the Bet Family Bromodomains.
Chun-wa Chung,Hervé Coste,Julia H. White,Olivier Mirguet,Jonathan I. Wilde,Romain Luc Marie Gosmini,Chris J. Delves,Sylvie M. Magny,Robert Woodward,Stephen A. Hughes,Eric Boursier,Helen R. Flynn,Anne Marie Jeanne Bouillot,Paul Bamborough,Jean-Marie Brusq,Françoise Gellibert,Emma J. Jones,Alizon M. Riou,Paul Homes,Sandrine Martin,Iain Uings,Jérôme Toum,Catherine A. Clément,Anne-Benedicte Boullay,Rachel Grimley,Florence Blandel,Rab K. Prinjha,Kevin Lee,Jorge Kirilovsky,Edwige Nicodeme +29 more
TL;DR: X-ray crystal structures of compounds bound into bromodomains of Brd2 and Brd4 elucidate the molecular interactions of binding and explain the precisely defined stereochemistry required for activity.
Journal ArticleDOI
Discovery of Novel Irreversible Inhibitors of Interleukin (IL)-2-inducible Tyrosine Kinase (Itk) by Targeting Cysteine 442 in the ATP Pocket
John D. Harling,Angela M. Deakin,Sebastien Andre Campos,Rachel Grimley,Laiq Chaudry,Catherine Nye,Oxana Polyakova,Christina M. Bessant,Nick Barton,Don O. Somers,John Barrett,Rebecca H. Graves,Laura Hanns,William J. Kerr,Roberto Solari +14 more
TL;DR: This study confirms the irreversible covalent binding of the inhibitor to the kinase by x-ray crystallography and enzymology while demonstrating potency, selectivity, and prolonged duration of action in in vitro biological assays.
Journal ArticleDOI
Over expression of wild type or a catalytically dead mutant of Sirtuin 6 does not influence NFκB responses.
Rachel Grimley,Oxana Polyakova,Jessica Vamathevan,Joanne McKenary,Brian Hayes,Champa Patel,Janet L. Smith,Angela Bridges,Andrew P. Fosberry,Anshu Bhardwaja,Bernadette Mouzon,Chun-wa Chung,Nathalie Barrett,Nicola J. Richmond,Sundip Modha,Roberto Solari +15 more
TL;DR: It is confirmed in cellular assays that SIRT6 can deacetylate acetylated-histone H3 lysine 9 (H3K9Ac), however this de acetylase activity is unusually low in biochemical assays.
Journal ArticleDOI
Interaction of Nucleotides with the NAD(H)-binding Domain of the Proton-translocating Transhydrogenase of Rhodospirillum rubrum
Tania Bizouarn,Christine P. Diggle,Philip G. Quirk,Rachel Grimley,Nick P.J. Cotton,Christopher M. Thomas,J. Baz Jackson +6 more
TL;DR: The difference in the binding affinity between NADH and NAD indicates that there may be an energy requirement for the transfer of reducing equivalents into this site in the complete enzyme under physiological conditions, and suggests that the loop has closed down to within 0.5 nm of the nucleotide.
Journal ArticleDOI
Identification of novel interacting partners of Sirtuin6.
TL;DR: A number of interacting partners are reported which strengthen previous findings that SIRT6 functions in base excision repair (BER), and novel interactors which suggest a role in nucleosome and chromatin remodeling, the cell cycle and NFκB biology.